RAC 2.92% $1.94 race oncology ltd

Ann: Quarterly Activity Report & Appendix 4C, page-82

  1. 2,649 Posts.
    lightbulb Created with Sketch. 10156
    While this overall assessment of the different pillars is approximately correct, the FTO-directed Stratum 2 of the EMD AML trial does rather change this. Pillar 3 is now a mix of Pillar 1 FTO with the historical chemotherapy Pillar 3 pathway.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.